Page last updated: 2024-09-03

celastrol and Osteoporosis

celastrol has been researched along with Osteoporosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guo, L; Li, J; Li, Q; Luo, X; Wang, Y; Wu, G; Xi, J	1
Cai, F; Liu, L; Liu, X; Yang, A; Zhang, Y	1

Other Studies

2 other study(ies) available for celastrol and Osteoporosis

Article	Year
Celastrol inhibits glucocorticoid‑induced osteoporosis in rat via the PI3K/AKT and Wnt signaling pathways. Molecular medicine reports, 2018, Volume: 18, Issue:5 Topics: Animals; Body Weight; Calcium; Cell Differentiation; Collagen Type I; Disease Models, Animal; Gene Expression Regulation; Glucocorticoids; Humans; Male; Oncogene Protein v-akt; Osteocalcin; Osteoporosis; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Rats; Tartrate-Resistant Acid Phosphatase; Triterpenes; Wnt Signaling Pathway	2018
Celastrol, an NF-κB inhibitor, ameliorates hypercalciuria and articular cartilage lesions in a mouse model of secondary osteoporosis. Journal of pharmacological sciences, 2016, Volume: 130, Issue:4 Topics: Adipose Tissue; Animals; Body Weight; Cartilage, Articular; Disease Models, Animal; Disease Progression; Hypercalciuria; Leptin; Lipid Metabolism; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; NF-kappa B; Osteoporosis; Parathyroid Hormone; Pentacyclic Triterpenes; Triterpenes	2016

Article

Year

Celastrol inhibits glucocorticoid‑induced osteoporosis in rat via the PI3K/AKT and Wnt signaling pathways.

Molecular medicine reports, 2018, Volume: 18, Issue:5

Topics: Animals; Body Weight; Calcium; Cell Differentiation; Collagen Type I; Disease Models, Animal; Gene Expression Regulation; Glucocorticoids; Humans; Male; Oncogene Protein v-akt; Osteocalcin; Osteoporosis; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Rats; Tartrate-Resistant Acid Phosphatase; Triterpenes; Wnt Signaling Pathway

2018

Celastrol, an NF-κB inhibitor, ameliorates hypercalciuria and articular cartilage lesions in a mouse model of secondary osteoporosis.

Journal of pharmacological sciences, 2016, Volume: 130, Issue:4

Topics: Adipose Tissue; Animals; Body Weight; Cartilage, Articular; Disease Models, Animal; Disease Progression; Hypercalciuria; Leptin; Lipid Metabolism; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; NF-kappa B; Osteoporosis; Parathyroid Hormone; Pentacyclic Triterpenes; Triterpenes

2016